• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Moving toward personalized breast cancer screening: The role of Primary Care].迈向个性化乳腺癌筛查:初级保健的作用
Aten Primaria. 2022 May;54(5):102288. doi: 10.1016/j.aprim.2022.102288. Epub 2022 Apr 25.
2
Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.个体化治疗时代的乳腺癌筛查:基于风险和偏好的人群水平策略的概念模型和美国国家癌症研究所倡议。
Cancer. 2014 Oct 1;120(19):2955-64. doi: 10.1002/cncr.28771. Epub 2014 May 15.
3
Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.自2009年美国预防服务工作组(USPSTF)指南发布以来乳腺癌筛查间隔的变化
J Womens Health (Larchmt). 2017 Aug;26(8):820-827. doi: 10.1089/jwh.2016.6076. Epub 2017 Feb 8.
4
Feasibility and Acceptability of Personalized Breast Cancer Screening (DECIDO Study): A Single-Arm Proof-of-Concept Trial.基于个体的乳腺癌筛查的可行性和可接受性(DECIDO 研究):一项单臂概念验证试验。
Int J Environ Res Public Health. 2022 Aug 21;19(16):10426. doi: 10.3390/ijerph191610426.
5
Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s.促进关于乳腺癌筛查的明智决策:针对40多岁女性的基于网络的决策辅助工具的开发与评估
BMC Med Inform Decis Mak. 2017 Mar 21;17(1):29. doi: 10.1186/s12911-017-0423-7.
6
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.乳腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Feb 16;164(4):279-96. doi: 10.7326/M15-2886. Epub 2016 Jan 12.
7
A Review of the Literature for Individualizing Women's Care Through Breast Cancer Risk Assessment.通过乳腺癌风险评估实现女性个体化护理的文献综述。
Nurs Womens Health. 2023 Jun;27(3):220-230. doi: 10.1016/j.nwh.2022.12.006. Epub 2023 May 5.
8
Recommendations on prevention and screening for breast cancer in Hong Kong.香港乳腺癌预防及筛查建议
Hong Kong Med J. 2018 Jun;24(3):298-306. doi: 10.12809/hkmj177037.
9
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.女性对基于个性化风险的乳腺癌筛查和预防的认知:一项国际焦点小组研究。
Psychooncology. 2019 May;28(5):1056-1062. doi: 10.1002/pon.5051. Epub 2019 Mar 25.
10
Key Elements of Mammography Shared Decision-Making: a Scoping Review of the Literature.乳腺 X 线摄影共享决策的关键要素:文献的范围综述。
J Gen Intern Med. 2018 Oct;33(10):1805-1814. doi: 10.1007/s11606-018-4576-6. Epub 2018 Jul 20.

引用本文的文献

1
[Cancer prevention recommendations: Update 2024].[癌症预防建议:2024年更新]
Aten Primaria. 2024 Nov;56 Suppl 1(Suppl 1):103128. doi: 10.1016/j.aprim.2024.103128.
2
[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022].[PAPPS专家小组。癌症预防建议:2022年更新]
Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102440. doi: 10.1016/j.aprim.2022.102440.

本文引用的文献

1
Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours.基层医疗中乳腺癌风险评估与一级预防建议:对医疗服务提供者态度和常规行为的系统评价
Cancers (Basel). 2021 Aug 18;13(16):4150. doi: 10.3390/cancers13164150.
2
Healthcare professionals' behaviour regarding the implementation of shared decision-making in screening programmes: A systematic review.卫生保健专业人员在筛查项目中实施共同决策的行为:系统评价。
Patient Educ Couns. 2021 Aug;104(8):1933-1944. doi: 10.1016/j.pec.2021.01.032. Epub 2021 Jan 30.
3
[PAPPS Cancer Expert Group. Cancer Prevention Recommendations. 2020 PAPPS update].[PAPPS癌症专家小组。癌症预防建议。2020年PAPPS更新版]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):44-69. doi: 10.1016/j.aprim.2020.09.003.
4
[Analysis of the situation, evaluation and improvement proposals of the Preventive Activities and Health Promotion Program (PAPPS)].[预防活动与健康促进计划(PAPPS)的情况分析、评估及改进建议]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):161-172. doi: 10.1016/j.aprim.2020.09.002.
5
Personalized early detection and prevention of breast cancer: ENVISION consensus statement.乳腺癌个体化早期检测和预防:ENVISION 共识声明。
Nat Rev Clin Oncol. 2020 Nov;17(11):687-705. doi: 10.1038/s41571-020-0388-9. Epub 2020 Jun 18.
6
[Informed choice in breast cancer screening: the role of education].[乳腺癌筛查中的知情选择:教育的作用]
Gac Sanit. 2021 May-Jun;35(3):243-249. doi: 10.1016/j.gaceta.2020.01.002. Epub 2020 Mar 12.
7
Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.多基因乳腺癌风险的临床应用:新兴领域的批判性评价与展望。
Breast Cancer Res. 2020 Feb 17;22(1):21. doi: 10.1186/s13058-020-01260-3.
8
Personalized breast cancer screening strategies: A systematic review and quality assessment.个性化乳腺癌筛查策略:系统评价与质量评估。
PLoS One. 2019 Dec 16;14(12):e0226352. doi: 10.1371/journal.pone.0226352. eCollection 2019.
9
Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.乳腺 X 线摄影术的获益和危害信息对女性决策的影响:InforMa 随机对照试验。
PLoS One. 2019 Mar 26;14(3):e0214057. doi: 10.1371/journal.pone.0214057. eCollection 2019.
10
Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.针对乳腺癌风险未增加的40至74岁女性乳腺癌筛查的建议。
CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463.

迈向个性化乳腺癌筛查:初级保健的作用

[Moving toward personalized breast cancer screening: The role of Primary Care].

作者信息

Pons-Rodriguez Anna, Marzo-Castillejo Mercè, Cruz-Esteve Inés, Galindo-Ortego Gisela, Hernández-Leal Maria José, Rué Montserrat

机构信息

ABS Eixample, Institut Català de la Salut, Lleida, España.

Unitat de Suport a la Recerca Metropolitana Sud, IDIAP Jordi Gol, Direcció d'Atenció Primària Costa de Ponent, Institut Català de la Salut, Barcelona, España.

出版信息

Aten Primaria. 2022 May;54(5):102288. doi: 10.1016/j.aprim.2022.102288. Epub 2022 Apr 25.

DOI:10.1016/j.aprim.2022.102288
PMID:35477080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9061619/
Abstract

Breast cancer is the leading cause of death in the world among women. The Spanish National Health System (SNHS) introduced population-based breast cancer screening in 1990. As in most European programs, risk is identified on the basis of age and a mammogram is offered every two years to women aged 50-69 years. Scientific evidence is moving toward personalized screening, based on individual risk. This article presents the clinical trials that will evaluate the efficacy of personalized screening and some studies carried out in our environment on the effect of informing women of the benefits and adverse effects of screening or the acceptability and feasibility of offering personalized screening, in the Shared Decision Making context. The Preventive Activities and Health Promotion Program can help transform screening in our SNHS.

摘要

乳腺癌是全球女性的首要死因。西班牙国家卫生系统(SNHS)于1990年引入了基于人群的乳腺癌筛查。与大多数欧洲项目一样,风险是根据年龄来确定的,每两年为50至69岁的女性提供一次乳房X光检查。科学证据正朝着基于个体风险的个性化筛查发展。本文介绍了将评估个性化筛查效果的临床试验,以及在我们的环境中开展的一些研究,这些研究涉及在共同决策背景下告知女性筛查的益处和不良影响,或提供个性化筛查的可接受性和可行性。预防活动与健康促进项目有助于改变我们SNHS中的筛查方式。